Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
Holding GYRE?
Track your performance easily
GYRE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$8.26 - $30.40
Previous Close$12.91
Volume91.30K
Average Volume (3M)56.20K
Market Cap
$1.21B
Enterprise Value$1.22B
Total Cash (Recent Filing)$25.10M
Total Debt (Recent Filing)$1.96M
Price to Earnings (P/E)―
Beta0.63
Next Earnings
Apr 01, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jan 13, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-17.57
Shares Outstanding93,521,434
10 Day Avg. Volume85,051
30 Day Avg. Volume56,200
Standard Deviation1.35
R-Squared0.03
Alpha0.28
Financial Highlights & Ratios
Price to Book (P/B)19.86
Price to Sales (P/S)7.29
Price to Cash Flow (P/CF)-55.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue14.91
Enterprise Value/Gross Profit11.19
Enterprise Value/Ebitda53.32
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Gyre Therapeutics News
PremiumCompany Announcements
Gyre Therapeutics Reports Q3 2024 Financial Results and Strategic Updates
PremiumCompany Announcements
Gyre Therapeutics Welcomes Dr. Epstein to Leadership Team
PremiumCompany Announcements
Gyre Therapeutics Seeks Compliance Amid Board ReshuffleOwnership Overview
71.48% Insiders
0.54% Mutual Funds
0.05% Other Institutional Investors
27.20% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GYRE FAQ
What was Gyre Therapeutics’s price range in the past 12 months?
Gyre Therapeutics lowest stock price was $8.26 and its highest was $30.40 in the past 12 months.
What is Gyre Therapeutics’s market cap?
Currently, no data Available
When is Gyre Therapeutics’s upcoming earnings report date?
Gyre Therapeutics’s upcoming earnings report date is Apr 01, 2025 which is in 130 days.
How were Gyre Therapeutics’s earnings last quarter?
Gyre Therapeutics released its earnings results on Nov 13, 2024. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of N/A by $0.01.
Is Gyre Therapeutics overvalued?
According to Wall Street analysts Gyre Therapeutics’s price is currently Overvalued.
Does Gyre Therapeutics pay dividends?
Gyre Therapeutics pays a Annually dividend of $3.59 which represents an annual dividend yield of N/A. See more information on Gyre Therapeutics dividends here
What is Gyre Therapeutics’s EPS estimate?
Gyre Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gyre Therapeutics have?
Gyre Therapeutics has 93,521,430 shares outstanding.
What happened to Gyre Therapeutics’s price movement after its last earnings report?
Gyre Therapeutics reported an EPS of $0.01 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -9.557%.
Which hedge fund is a major shareholder of Gyre Therapeutics?
Currently, no hedge funds are holding shares in GYRE
---
Gyre Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
GYRE Sentiment 50%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 6.0%
Last 30 Days ▼ 6.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-12.05%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
1156.92%
Trailing 12-Months
Company Description
Gyre Therapeutics
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.
---
Technical Analysis
---